These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37288608)

  • 1. Comment on article by Poostiyan et al.: Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
    Wang M; Yang C
    J Cosmet Dermatol; 2023 Oct; 22(10):2865. PubMed ID: 37288608
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranexamic acid microinjections versus tranexamic acid mesoneedling in the treatment of facial melasma: A randomized assessor-blind split-face controlled trial.
    Poostiyan N; Alizadeh M; Shahmoradi Z; Fatemi Naeini F
    J Cosmet Dermatol; 2023 Apr; 22(4):1238-1244. PubMed ID: 36606390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
    Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
    J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
    Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
    Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
    Kuster Kaminski Arida D; Orso Rebellato PR; Marioto de Campos GL; Costa A; Vilaverde Schmitt J; Larocca Skare T; Rodrigues Lisboa Faucz L
    J Cosmet Dermatol; 2021 Dec; 20(12):4005-4010. PubMed ID: 34077619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypopigmentation as a side effect of melasma treatment with tranexamic acid intradermal microinjections.
    Litaiem N; Daadaa N; Karray M; Chamli A; Zeglaoui F
    Dermatol Ther; 2020 Jul; 33(4):e13503. PubMed ID: 32358856
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
    Saki N; Darayesh M; Heiran A
    J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
    Laothaworn V; Juntongjin P
    J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
    [No Abstract]   [Full Text] [Related]  

  • 12. Melasma treatment with oral tranexamic acid and a novel adjuvant topical therapy.
    Cohen PR
    Cutis; 2018 Aug; 102(2):106. PubMed ID: 30235369
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and possible mechanisms of topical tranexamic acid in melasma.
    Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY
    Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tranexamic acid for the treatment of melasma.
    Ali FR
    Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
    Malik F; Hanif MM; Mustafa G
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of oral vs different dilutions of intradermal tranexamic acid microinjections in melasma-A randomized clinical trial.
    El Hadidi H; Mosaad R; Ragab N
    Dermatol Ther; 2021 May; 34(3):e14924. PubMed ID: 33651442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging importance of tranexamic acid in dermatology.
    Forbat E; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2020 Jun; 45(4):445-449. PubMed ID: 31663643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of functional microarray of microneedles combined with topical tranexamic acid for melasma: A randomized, self-controlled, split-face study.
    Xu Y; Ma R; Juliandri J; Wang X; Xu B; Wang D; Lu Y; Zhou B; Luo D
    Medicine (Baltimore); 2017 May; 96(19):e6897. PubMed ID: 28489798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.